EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma.

Xu, Shan; Ma, Bohan; Feng, Xiaoyu; Yao, Chen; Jian, Yanlin; Chen, Yule; Wang, Xinyang; Xie, Hongjun; Li, Lei.

Afiliação

Xu S; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ma B; Oncology Research Laboratory, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an, China.
Feng X; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yao C; Oncology Research Laboratory, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an, China.
Jian Y; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Chen Y; Oncology Research Laboratory, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an, China.
Wang X; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xie H; Oncology Research Laboratory, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an, China.
Li L; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.